US Patent 7732476 Leukemia treatment method and composition
Patent 7732476 was granted and assigned to University of South Florida on June, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+289 characters)
Article
Patent abstract
A method of inducing high anti-leukemia activity responsive to the combination of hydroxamic acid analogue histone deacetylase inhibitors and PKC412 against human acute leukemia characterized as expressing phosphorylated (p)FLT3 kinase by a novel flow cytometry-based assay.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Kapil N Bhalla0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07732476 Leukemia treatment method and composition US Patent 7732476 Leukemia treatment method and composition
Infobox
Patent Number
077324760
Patent Number
77324760
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077324760
Date of Patent
June 8, 2010
0Patent Application Number
113072980
Date Filed
January 31, 2006
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07732476 Leukemia treatment method and composition
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07732476
Date of patent
June 8, 2010
Patent application number
11307298
Date Filed
January 31, 2006
Patent primary examiner
Find more entities like US Patent 7732476 Leukemia treatment method and composition
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.